STAGE IV RENAL CELL CANCER
Clinical trials for STAGE IV RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for advanced kidney cancer
Disease control OngoingThis study tested two drugs, pazopanib and bevacizumab, given in turns to people with advanced kidney cancer that had spread. The goal was to find the best dose and see if the combination helps control the disease. 51 patients took part, and the study looked at side effects and h…
Matched conditions: STAGE IV RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
New drug cocktail shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called ceralasertib, either alone or combined with olaparib or durvalumab, in people with advanced solid tumors like kidney, bladder, pancreatic, endometrial, and prostate cancers. The goal is to see if these combinations can shrink tumors or slow their gr…
Matched conditions: STAGE IV RENAL CELL CANCER
Phase: PHASE2 • Sponsor: Rahul Aggarwal • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Could a two-drug combo slow kidney cancer better than one?
Disease control OngoingThis study tests whether adding an experimental immune-boosting drug (anti-OX40 antibody) to the standard targeted therapy axitinib helps control advanced kidney cancer better than axitinib alone. About 62 adults whose cancer worsened after prior immunotherapy will receive either…
Matched conditions: STAGE IV RENAL CELL CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 13, 2026 15:59 UTC